BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23663987)

  • 21. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 22. Publication bias of randomized controlled trials in emergency medicine.
    Ospina MB; Kelly K; Klassen TP; Rowe BH
    Acad Emerg Med; 2006 Jan; 13(1):102-8. PubMed ID: 16365332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory considerations in the design of comparative observational studies using propensity scores.
    Yue LQ
    J Biopharm Stat; 2012; 22(6):1272-9. PubMed ID: 23075022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpretation of observational studies.
    Polychronopoulou A; Pandis N
    Am J Orthod Dentofacial Orthop; 2014 Dec; 146(6):815-7. PubMed ID: 25432264
    [No Abstract]   [Full Text] [Related]  

  • 26. Meta-analyses including data from observational studies.
    O'Connor AM; Sargeant JM
    Prev Vet Med; 2014 Feb; 113(3):313-22. PubMed ID: 24268538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interpretation of tests of heterogeneity and bias in meta-analysis.
    Ioannidis JP
    J Eval Clin Pract; 2008 Oct; 14(5):951-7. PubMed ID: 19018930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of repeated measures study designs.
    Peters JL; Mengersen KL
    J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to make sense of clinical research.
    Wooten JM; Ross VM
    RN; 2005 Jan; 68(1):22-7; quiz 28. PubMed ID: 15742745
    [No Abstract]   [Full Text] [Related]  

  • 30. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions.
    Villar J; Carroli G
    Prev Med; 1996; 25(3):365-75. PubMed ID: 8781015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From randomized trials to registry studies: translating data into clinical information.
    Brown ML; Gersh BJ; Holmes DR; Bailey KR; Sundt TM
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):613-20. PubMed ID: 18679381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 34. Meta-analysis: when and how.
    Imperiale TF
    Hepatology; 1999 Jun; 29(6 Suppl):26S-31S. PubMed ID: 10386080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.
    Little RJ; Rubin DB
    Annu Rev Public Health; 2000; 21():121-45. PubMed ID: 10884949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses.
    Vaitkus PT; Brar C
    Am Heart J; 2007 Feb; 153(2):275-80. PubMed ID: 17239689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials.
    Ioannidis JP; Trikalinos TA
    J Clin Epidemiol; 2005 Jun; 58(6):543-9. PubMed ID: 15878467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors, confounding, and the illusion of statistical control.
    Christenfeld NJ; Sloan RP; Carroll D; Greenland S
    Psychosom Med; 2004; 66(6):868-75. PubMed ID: 15564351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primer: strengths and weaknesses of meta-analysis.
    Finckh A; Tramèr MR
    Nat Clin Pract Rheumatol; 2008 Mar; 4(3):146-52. PubMed ID: 18227829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.